Background: COVID-19 is an infectious disease caused by a novel coronavirus (SARS-CoV-2). The immunopathogenesis of the infection is currently unknown. Healthcare workers (HCWs) are at highest risk of infection and disease. Aim of the study was to assess the sero-prevalence of SARS-CoV-2 in an Italian cohort of HCWs exposed to COVID-19 patients. Methods: A point-of-care lateral flow immunoassay (BioMedomics IgM-IgG Combined Antibody Rapid Test) was adopted to assess the prevalence of IgG and IgM against SARS-CoV-2. It was ethically approved ("Milano Area 1"Ethical Committee prot. n. 2020/ST/057). Results: A total of 202 individuals (median age 45 years; 34.7% males) were retrospectively recruited in an Italian hospital (Milan, Italy). The percentage (95% CI) of recruited individuals with IgM and IgG were 14.4% (9.6-19.2%) and 7.4% (3.8-11.0%), respectively. IgM were more frequently found in males (24.3%), and in individuals aged 20-29 (25.9%) and 60-69 (30.4%) years. No relationship was found between exposure to COVID-19 patients and IgM and IgG positivity. Conclusions: The present study did show a low prevalence of SARS-CoV-2 IgM in Italian HCWs. New studies are needed to assess the prevalence of SARS-CoV-2 antibodies in HCWs exposed to COVID-19 patients, as well the role of neutralizing antibodies.
SARS-CoV-2 specific serological pattern in healthcare workers of an Italian COVID-19 forefront hospital / G. Sotgiu, A. Barassi, M.R. Miozzo, L. Saderi, A. Piana, N. Orfeo, C. Colosio, G. Felisati, M. Davi', A. Giovanni Gerli, S. Centanni. - In: BMC PULMONARY MEDICINE. - ISSN 1471-2466. - 20(2020 Jul 29), pp. 203.1-203.6. [10.1186/s12890-020-01237-0]
SARS-CoV-2 specific serological pattern in healthcare workers of an Italian COVID-19 forefront hospital
A. BarassiSecondo
Methodology
;M.R. MiozzoWriting – Original Draft Preparation
;C. ColosioValidation
;G. FelisatiMembro del Collaboration Group
;M. Davi'Data Curation
;S. CentanniUltimo
Writing – Review & Editing
2020
Abstract
Background: COVID-19 is an infectious disease caused by a novel coronavirus (SARS-CoV-2). The immunopathogenesis of the infection is currently unknown. Healthcare workers (HCWs) are at highest risk of infection and disease. Aim of the study was to assess the sero-prevalence of SARS-CoV-2 in an Italian cohort of HCWs exposed to COVID-19 patients. Methods: A point-of-care lateral flow immunoassay (BioMedomics IgM-IgG Combined Antibody Rapid Test) was adopted to assess the prevalence of IgG and IgM against SARS-CoV-2. It was ethically approved ("Milano Area 1"Ethical Committee prot. n. 2020/ST/057). Results: A total of 202 individuals (median age 45 years; 34.7% males) were retrospectively recruited in an Italian hospital (Milan, Italy). The percentage (95% CI) of recruited individuals with IgM and IgG were 14.4% (9.6-19.2%) and 7.4% (3.8-11.0%), respectively. IgM were more frequently found in males (24.3%), and in individuals aged 20-29 (25.9%) and 60-69 (30.4%) years. No relationship was found between exposure to COVID-19 patients and IgM and IgG positivity. Conclusions: The present study did show a low prevalence of SARS-CoV-2 IgM in Italian HCWs. New studies are needed to assess the prevalence of SARS-CoV-2 antibodies in HCWs exposed to COVID-19 patients, as well the role of neutralizing antibodies.File | Dimensione | Formato | |
---|---|---|---|
SARS-CoV-2 specific serological pattern inhealthcare workers of an Italian COVID-19forefront hospital.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
697.26 kB
Formato
Adobe PDF
|
697.26 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.